Related Experiment Videos
Staged revascularization in critically ill patients with coronary artery disease
N J Hayat1, K Varghese, C S Thomas
1Chest Diseases Hospital, Safat, Kuwait.
Insights
Percutaneous transluminal coronary angioplasty (PTCA) can stabilize high-risk patients with severe coronary artery disease, serving as a crucial bridge to coronary artery bypass graft (CABG) surgery.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Critically ill patients undergoing bypass surgery face elevated mortality and morbidity risks.
- High-risk patients with refractory unstable angina or cardiogenic shock present unique challenges in cardiac care.
Purpose of the Study:
- To evaluate the efficacy of percutaneous transluminal coronary angioplasty (PTCA) as a bridge to coronary artery bypass graft (CABG) surgery.
- To assess the value of PTCA in high-risk patients requiring revascularization.
Main Methods:
- Retrospective analysis of 11 critically ill patients with severe multivessel coronary artery disease.
- Culprit vessel PTCA performed as a preparatory procedure before surgical revascularization.
- Patients presented with refractory unstable angina, prior myocardial infarction, and/or cardiogenic shock.
Main Results:
- All 11 patients experienced a stable in-hospital course following PTCA.
- Seven patients successfully underwent subsequent CABG and are recovering well.
- Three patients opted for continued medical management after PTCA, despite advice for CABG.
Conclusions:
- Percutaneous transluminal coronary angioplasty of the culprit vessel can serve as a viable bridge to surgery.
- PTCA offers a stabilizing option for critically ill patients awaiting definitive surgical revascularization.
- This approach may improve outcomes for high-risk patients with complex coronary artery disease.
Background:
Critically ill patients undergoing bypass surgery experience a higher mortality and morbidity.
Hypothesis:
The study was undertaken to evaluate the efficacy and value of percutaneous transluminal coronary angioplasty (PTCA) as a bridge to coronary artery bypass graft surgery (CABG) in high-risk patients with refractory unstable angina or cardiogenic shock.
Methods:
We present 11 seriously unstable patients with severe multivessel coronary artery disease undergoing culprit vessel PTCA. Angioplasty was performed not as a definitive procedure but rather as a bridge to surgical revascularization. All the patients had sustained at least one myocardial infarction prior to catheterization, all had refractory unstable angina, eight patients had only a single patent coronary artery, and five patients were in cardiogenic shock.
Results:
Following PTCA, all patients enjoyed a stable in-hospital period. One patient died 12 weeks after successful PTCA while awaiting second CABG. Seven patients subsequently underwent CABG and are doing well. The remaining three patients were also advised to undergo CABG, but elected to continue medical management.
Conclusions:
Coronary angioplasty of the culprit vessel may play a role as a bridge to surgery in critically ill patients.